Insight Molecular Diagnostics (IMDX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$12.9 million.
- Insight Molecular Diagnostics' Other Gross PP&E Adjustments fell 1501.87% to -$12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.9 million, marking a year-over-year decrease of 1501.87%. This contributed to the annual value of -$11.5 million for FY2024, which is 2363.03% down from last year.
- As of Q3 2025, Insight Molecular Diagnostics' Other Gross PP&E Adjustments stood at -$12.9 million, which was down 1501.87% from -$12.6 million recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Other Gross PP&E Adjustments registered a high of $4.7 million during Q2 2021, and its lowest value of -$15.7 million during Q3 2022.
- Over the past 5 years, Insight Molecular Diagnostics' median Other Gross PP&E Adjustments value was -$11.1 million (recorded in 2023), while the average stood at -$8.1 million.
- As far as peak fluctuations go, Insight Molecular Diagnostics' Other Gross PP&E Adjustments soared by 44167.87% in 2021, and later plummeted by 46248.28% in 2023.
- Over the past 5 years, Insight Molecular Diagnostics' Other Gross PP&E Adjustments (Quarter) stood at -$4.5 million in 2021, then crashed by 203.02% to -$13.7 million in 2022, then surged by 32.45% to -$9.3 million in 2023, then decreased by 23.63% to -$11.5 million in 2024, then dropped by 12.64% to -$12.9 million in 2025.
- Its last three reported values are -$12.9 million in Q3 2025, -$12.6 million for Q2 2025, and -$12.7 million during Q1 2025.